Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)
Completed · Phase 3
Conditions studied: Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever
In brief
The purpose of this study is to evaluate the safety and tolerability of combined ciclesonide nasal spray administered along with a fixed combination of inhaled fluticasone dipropionate/salmeterol.
Key facts
- Study ID
- NCT00163488
- Run by
- AstraZeneca
- People needed
- 106
- Starts
- 2005-01-01
- Expected to finish
- 2005-08-01
- Last updated by the study team
- 2016-12-05
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Altana Pharma/Nycomed — Long Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.